These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

413 related articles for article (PubMed ID: 2327466)

  • 1. Leiomyosarcoma in a series of hysterectomies performed for presumed uterine leiomyomas.
    Leibsohn S; d'Ablaing G; Mishell DR; Schlaerth JB
    Am J Obstet Gynecol; 1990 Apr; 162(4):968-74; discussion 974-6. PubMed ID: 2327466
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Uterine Sarcomas in Patients Undergoing Surgery for Presumed Leiomyomas: 10 Years' Experience.
    Paul PG; Rengaraj V; Das T; Garg R; Thomas M; Khurd AS
    J Minim Invasive Gynecol; 2016; 23(3):384-9. PubMed ID: 26677821
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Hysterectomies performed for presumed leiomyomas: should the fear of leiomyosarcoma make us apprehend non laparotomic surgical routes?].
    Leung F; Terzibachian JJ; Gay C; Chung Fat B; Aouar Z; Lassabe C; Maillet R; Riethmuller D
    Gynecol Obstet Fertil; 2009 Feb; 37(2):109-14. PubMed ID: 19200764
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk of morcellation of uterine leiomyosarcomas in laparoscopic supracervical hysterectomy and laparoscopic myomectomy, a retrospective trial including 4791 women.
    Lieng M; Berner E; Busund B
    J Minim Invasive Gynecol; 2015; 22(3):410-4. PubMed ID: 25460521
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Uterine sarcoma in patients operated on for presumed leiomyoma and rapidly growing leiomyoma.
    Parker WH; Fu YS; Berek JS
    Obstet Gynecol; 1994 Mar; 83(3):414-8. PubMed ID: 8127535
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidence of Malignancy and Myoma Variants at Surgery for Presumed Benign Symptomatic Myomas.
    Damasco MR; Chan PK; Slonim M; Ang WC; Healey MG
    J Minim Invasive Gynecol; 2017; 24(4):659-664. PubMed ID: 28216458
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ACOG Committee Opinion No. 770: Uterine Morcellation for Presumed Leiomyomas.
    Obstet Gynecol; 2019 Mar; 133(3):e238-e248. PubMed ID: 30801477
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk of Undetected Cancer at the Time of Laparoscopic Supracervical Hysterectomy and Laparoscopic Myomectomy: Implications for the Use of Power Morcellation.
    Perkins RB; Handal-Orefice R; Hanchate AD; Lin M; Paasche-Orlow MK
    Womens Health Issues; 2016; 26(1):21-6. PubMed ID: 26701205
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of undiagnosed uterine leiomyosarcoma in women undergoing hysterectomy or myomectomy for benign indications.
    Lange S; Pluchino N; Fehlmann A; Marci R; Boukrid M; Jazia IB; Petignat P; Dubuisson J
    Eur J Obstet Gynecol Reprod Biol; 2017 Sep; 216():239-244. PubMed ID: 28743407
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence of occult leiomyosarcoma in presumed morcellation cases: a database study.
    Rodriguez AM; Zeybek B; Asoglu MR; Sak ME; Tan A; Borahay MA; Kilic GS
    Eur J Obstet Gynecol Reprod Biol; 2016 Feb; 197():31-5. PubMed ID: 26699101
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk of complications and uterine malignancies in women undergoing hysterectomy for presumed benign leiomyomas.
    Takamizawa S; Minakami H; Usui R; Noguchi S; Ohwada M; Suzuki M; Sato I
    Gynecol Obstet Invest; 1999; 48(3):193-6. PubMed ID: 10545745
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ACOG Committee Opinion No. 770 Summary: Uterine Morcellation for Presumed Leiomyomas.
    Obstet Gynecol; 2019 Mar; 133(3):604-605. PubMed ID: 30801469
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The management of uterine leiomyomas.
    Lefebvre G; Vilos G; Allaire C; Jeffrey J; Arneja J; Birch C; Fortier M; Wagner MS;
    J Obstet Gynaecol Can; 2003 May; 25(5):396-418; quiz 419-22. PubMed ID: 12738981
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Does fibroids surgery by endoscopy or laparotomy represent a malignancy threat?
    Mettler L; Abdusattarova K; Alkatout I
    Minerva Ginecol; 2017 Dec; 69(6):517-525. PubMed ID: 28696085
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Uterine Leiomyoma With Osteoclast-like Giant Cells.
    Guilbert MC; Samouëlian V; Rahimi K
    Int J Gynecol Pathol; 2016 Jan; 35(1):30-2. PubMed ID: 26166717
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Uterine leiomyosarcoma - incidence, treatment, and the impact of morcellation. A nationwide cohort study.
    Skorstad M; Kent A; Lieng M
    Acta Obstet Gynecol Scand; 2016 Sep; 95(9):984-90. PubMed ID: 27223683
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization and Preoperative Risk Analysis of Leiomyosarcomas at a High-Volume Tertiary Care Center.
    Peters A; Sadecky AM; Winger DG; Guido RS; Lee TTM; Mansuria SM; Donnellan NM
    Int J Gynecol Cancer; 2017 Jul; 27(6):1183-1190. PubMed ID: 28463949
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Uterine Leiomyosarcoma: Can MRI Differentiate Leiomyosarcoma From Benign Leiomyoma Before Treatment?
    DeMulder D; Ascher SM
    AJR Am J Roentgenol; 2018 Dec; 211(6):1405-1415. PubMed ID: 30354268
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Occult Leiomyosarcomas in a Canadian Province: A Retrospective Cohort Study.
    Wu CQ; Woo LY; Giede KC; Thiel J; Karreman E; Rattray DD
    J Obstet Gynaecol Can; 2019 Jan; 41(1):46-51. PubMed ID: 30341020
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Occult Uterine Sarcoma and Leiomyosarcoma: Incidence of and Survival Associated With Morcellation.
    Raine-Bennett T; Tucker LY; Zaritsky E; Littell RD; Palen T; Neugebauer R; Axtell A; Schultze PM; Kronbach DW; Embry-Schubert J; Sundang A; Bischoff K; Compton-Phillips AL; Lentz SE
    Obstet Gynecol; 2016 Jan; 127(1):29-39. PubMed ID: 26646120
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.